Travere Therapeutics, Inc.

Report date
9/30/2026
Quarter
2026 Q3
Filed
11/4/2026
Shares
342,504
Value ($000)
20,170
Weight
0.0%
2020 Q4 - 2026 Q3 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).